Med Life S.A. (BVB:M)
Romania · Delayed Price · Currency is RON 11.36
+0.08 (0.71%)
At close: Jun 8, 2026
Med Life Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Med Life stock has a consensus rating of "Hold" and an average price target of lei 9.97. The average 1-year stock price forecast is 12.24% lower than the current stock price, while the lowest is lei 7.10 (-37.50%) and the highest is lei 11.70 (+2.99%).
Price Target: lei 9.97 (-12.24%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Med Life stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Hold | 3 | 2 | 2 | 2 | 2 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 5 | 3 | 3 | 3 | 4 |
Financial Forecast
Revenue This Year
3.52B
from 3.17B
Increased by 10.87%
Revenue Next Year
3.89B
from 3.52B
Increased by 10.44%
EPS This Year
0.22
from 0.02
Increased by 1,275.00%
EPS Next Year
0.34
from 0.22
Increased by 54.55%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is RON.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.5B | ||
| Avg | 3.5B | ||
| Low | 3.5B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 10.9% | ||
| Avg | 10.9% | ||
| Low | 10.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.22 | ||
| Avg | 0.22 | ||
| Low | 0.22 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1,275.0% | ||
| Avg | 1,275.0% | ||
| Low | 1,275.0% |